[go: up one dir, main page]

Puri et al., 2009 - Google Patents

Derivatives of human β-Casein fragments (54–59) exhibit highly potent immunosuppressant activity

Puri et al., 2009

View PDF
Document ID
11805753719700783099
Author
Puri A
Bhattacharya M
Tripathi L
Haq W
Publication year
Publication venue
International immunopharmacology

External Links

Snippet

Human β-casein fragment (54–59) having the amino acid sequence Val–Glu–Pro–Ile–Pro– Tyr, has shown potent immunostimulant activity. Several analogs of this hexapeptide have been synthesized with modification at the N-terminal region and two analogs, viz. peptide I …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links

Similar Documents

Publication Publication Date Title
AU754876B2 (en) Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
DE69326064T2 (en) Human protein P53 peptides for use in human cytotoxic T cell response inducing compositions and human P53 protein specific T lymphocytes
CN102438643B (en) Compositions and methods for treatment of celiac disease
US20040208863A1 (en) Anti-inflammatory activity from lactic acid bacteria
WO2002085933A1 (en) Toll-like receptor 5 ligands and methods of use
KR101184833B1 (en) Compositions for mucosal and oral administration comprising HCG fragments
CN107176995A (en) A kind of biologically active polypeptide SKVLPVPEKAVPYPQ and its preparation method and application
EP2133693A1 (en) Evaluation method and screening method for substance having action of activating/suppressing innate immunity, agent and food product for activating/suppressing innate immune mechanism and method for producing the same
RU2714117C2 (en) Peptide obtained from gpc3, pharmaceutical composition for treating or preventing cancer using it, immunity inducer and method for producing antigen-presenting cells
JP2014508164A (en) Compositions and methods for the treatment of intracellular damage
CN107586318A (en) A kind of blood pressure lowering peptide and preparation method thereof
Blum et al. Interactions between commensal bacteria and mucosal immunocompetent cells
Kim et al. CD8+ T cells directed against a peptide Epitope derived from peptidoglycan-associated lipoprotein of Legionella pneumophila confer disease protection
Puri et al. Derivatives of human β-Casein fragments (54–59) exhibit highly potent immunosuppressant activity
JP2001508435A (en) Myelopeptides and their medical uses
ES2350039T3 (en) IMMUNOMODULATING COMPOUNDS CONTAINING GAMMA-GLUTAMILO AND BETA-ASPARTILO AND METHODS WITH THEM.
Sollner et al. Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties
Pasikowski et al. A novel immunosuppressory peptide originating from the ubiquitin sequence
WO1997019691A1 (en) Gamma-l-glutamyl containing immunomodulator compounds and methods therewith
Liu et al. The immunostimulatory effect of bio-active peptide from pollen on murine and human lymphocytes
Stępnik et al. The influence of bovine casein-derived exorphins on mast cells in rodents
JPS6225679B2 (en)
US7326684B2 (en) Peptides for enhancing resistance to microbial infections
Viskova et al. Immunostimulatory activity of Milife, a novel immunomodulator of fungus origin
Adam¹ et al. Muramyl peptides